Clinical Trials in Washington

Showing 3421-3440 of 9,462 trials

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

This is a multi-center, open-label Phase 0 Master Protocol designed to study the localized pharmacodynamics (PD) of anti-cancer therapies within the tumor microenvironment (TME) when administered intratumorally in microdose quantities via the CIVO device in patients with surface accessible solid tumors for which there is a scheduled surgical intervention. CIVO stands for Comparative In Vivo Oncology. Multiple substudies will include specified investigational agents and combinations to be evaluated.

Solid Tumor

Presage Biosciences15 participantsStarted Jul 2021

Sacramento, California, United States • Atlanta, Georgia, United States • Shreveport, Louisiana, United States +9 more locations

COMPLETEDPhase 242 miles

Letrozole for Lymphangioleiomyomatosis

NCT01353209

The hypothesis in this study is that estrogen suppression by an aromatase inhibitor in postmenopausal women with lymphangioleiomyomatosis (LAM) will prevent or delay progression of lung disease and result in a decrease in the rate of decline in FEV1

Lymphangioleiomyomatosis

University of Cincinnati17 participantsStarted May 2011

Stanford, California, United States • Jacksonville, Florida, United States • Miami, Florida, United States +6 more locations

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Letrozole for Lymphangioleiomyomatosis

Find Trials by Condition in Washington

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Cancer Stem Cell High-Throughput Drug Screening Study

A Pilot RCT of the PRISM Intervention for AYAs With Cancer

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

Chronic Obstructive Pulmonary Disease and Community Health Worker Home-visits

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

A Study of MRx-4DP0004 in Asthma

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study